January 23, 2007 - Solos Endoscopy, Inc. announced its worldwide launch of its new Solos Breast Endoscopy System used for performing Mammary Ductoscopy procedures, enabling physicians to examine the mammary ducts under direct visualization.
According to Solo Endoscopy, clinical studies have shown that Breast Endoscopy (Mammary Ductoscopy) is capable of visualizing lesions consistent with ADH and early stages of cancer at dramatically smaller sizes than is currently possible through mammography. Physicians reportedly can find breast cancer and precancerous breast lesions as small as 0.2mm in diameter – 25 times smaller than is typically seen on a standard mammogram. It is possible, therefore, for tumors to be found up to five years earlier, while still confined within the mammary ducts where treatment survival rates of 99 percent have been reported.
May 19, 2026 
